Carbetocin for planned cesarean section and its effect on the heart
Treatments studied
Part of Heart & circulation clinical trials.
This trial studies how a medication called carbetocin affects the heart during a planned cesarean section. Carbetocin helps the uterus contract after delivery to reduce bleeding, and researchers want to see if it changes heart function in healthy women.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a planned (elective) cesarean section.
- You do not have heart or blood vessel problems like pre-eclampsia.
- You do not have a bleeding disorder.
- You are not allergic to the study drug carbetocin.
- Your body mass index (BMI) is under 50.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two medicines—carbetocin and oxytocin—given during a planned cesarean to help prevent heavy bleeding after delivery. It is for women who have certain risk factors for uterine atony (when the uterus does not tighten up after birth).
This study tests if giving carbetocin with calcium helps the uterus contract better after a planned c-section. It's for women at 37+ weeks without high risk for poor uterine tone.
This study looks at how well different doses of a contraction medicine work after an initial dose in women having a planned C-section. It may help find the best way to prevent bleeding after birth.
This trial tests if adding calcium changes how well a drug called carbetocin works to make the uterus contract after a planned C-section. It may help doctors prevent heavy bleeding after delivery.
This trial studies how three medications (ephedrine, phenylepinephrine, and norepinephrine) affect the contraction strength of uterine muscle tissue from pregnant people with type 2 or gestational diabetes during planned C-sections. It aims to understand if these drugs act differently in people with diabetes, which could help tailor safer treatments for low blood pressure during surgery.
This trial tests two medicines given during a planned C-section to see which is better at preventing heavy bleeding. It may help make delivery safer for healthy women having a scheduled cesarean.
Hear when a new Cesarian Section trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.